Effect of Self-Administration Versus Provider-Administered Injection of Subcutaneous Depot Medroxyprogesterone Acetate on Continuation Rates in Malawi: a Randomised Controlled Trial
Injectable contraceptives are popular in sub-Saharan Africa but have high discontinuation rates due partly to the need for provider-administered re-injection. We compared continuation rates of women who self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) and women who received DMPA-SC from a healthcare provider, including community health workers (CHWs).
Length:
11
Year:
2018
Organization:
FHI 360
College of Medicine, University of Malawi
Languages:
English